Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism
Focus on Health : Emphasize overall health overweight, including blood sugar and cholesterol levels
Typical dosing range: 200-1000 mcg subcutaneously, five nights on/two nights off, with initial dosing for females often starting at 0.1-0.3 mg daily and adjusted based on individual response and lab findings
What we deemed The Biggest Breakthrough in OSA Since CPAP Bottom Line The FDAs approval of the Wegovy weight-loss pill represents a seminal moment in obesity care transitioning effective GLP-1 pharmacotherapy from injectables to a once-daily tablet
(PubMed) Qin B, Xun P, Jacobs DR, Jr., et al
References Sinha, R., et al